Brief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
14/05/2026 20:29
May 14 (Reuters) - Crescita Therapeutics Inc CTX.TO: CRESCITA OBTAINS SHAREHOLDER APPROVAL TO BE ACQUIRED BY CLINACTIV HOLDINGS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium